...
首页> 外文期刊>BMJ: British medical journal >NICE lifts cost limit on drugs to improve access to end of life treatments
【24h】

NICE lifts cost limit on drugs to improve access to end of life treatments

机译:好的电梯成本限制药物来改善结束生命的治疗

获取原文
获取原文并翻译 | 示例
           

摘要

The NHS drugs watch dog has loosened the terms of approval forexpensive treatrnentsthat extend life in patients with a short life expectancy. Drugs that would normally be ruled out of use on the NHS because they did not represent a cost effective use of resources are now more likely to be made available. The National institute for Health and Clinical Excellence (NICE) has issued its appraisal committees with supplementary advice when considering whether to approve treatments licensed for terminal illness that affect small numbers of patients, normally fewer than 7000 new patients a year. The advice came into effect from 5 January.
机译:NHS药物观察狗松散的条款批准forexpensive treatrnentsthat延长生命患者的预期寿命短。,通常会排除使用国民健康保险制度,因为他们并不代表成本现在更有可能有效利用资源可用。健康和临床(NICE)已经发布了它与补充鉴定委员会建议在考虑是否批准治疗许可的绝症影响小数量的病人,通常更少每年超过7000新病人。从1月5日生效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号